Cargando…

Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes

Pancreatic cancer (PC) is notoriously difficult to diagnosis and properly stage resulting in incorrect primary treatment. Diagnostic and prognostic biomarkers are desperately needed to more accurately stage patients and select proper treatments. Recently, a newly discovered circulating stromal cell,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardner, Kirby P., Aldakkak, Mohammed, Tang, Cha-Mei, Tsai, Susan, Adams, Daniel L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979885/ https://www.ncbi.nlm.nih.gov/pubmed/33742084 http://dx.doi.org/10.1038/s41698-021-00161-8

Ejemplares similares

CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer
por: Gardner, Kirby P., et al.
Publicado: (2022)

Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer
por: Kasabwala, Dimpal M., et al.
Publicado: (2022)

Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer
por: Gardner, Kirby P., et al.
Publicado: (2022)

Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer
por: Wittmann, David, et al.
Publicado: (2020)

Tumour Size and T-Stage in Pancreatic Cancer Resection Specimens Depend on the Pathology Examination Approach
por: Tran, My Linh, et al.
Publicado: (2022)

Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer
por: Lim, Minji, et al.
Publicado: (2021)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome
por: Raghavakaimal, Ashvathi, et al.
Publicado: (2022)

Interpretation of Pathologic Margin after Endoscopic Resection of Gastrointestinal Stromal Tumor
por: Kim, Sang Gyun
Publicado: (2016)

Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining
por: Adams, Daniel L, et al.
Publicado: (2016)

Retroperitoneal Extragastrointestinal Stromal Tumor: Radiologic Pathologic Correlation
por: Watal, Pankaj, et al.
Publicado: (2014)

Ovarian microcystic stromal tumor: Radiologic-pathologic correlation
por: Jeong, Daniel, et al.
Publicado: (2018)

Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma
por: Chen, Yunyang, et al.
Publicado: (2019)

Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer
por: Yin, Feng, et al.
Publicado: (2020)

S100A4 expression is associated with poor prognosis in patients with resectable gastrointestinal stromal tumor
por: Shen, Wenlong, et al.
Publicado: (2019)

Aberrant TRPC1 expression reflects stromal cervical invasion, lymphovascular invasion, elevated FIGO stage, and poor survival in resectable endometrial carcinoma patients
por: Wang, Yi, et al.
Publicado: (2022)

Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer
por: Tahkola, Kyösti, et al.
Publicado: (2021)

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Dopico, Pablo J., et al.
Publicado: (2022)

Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma
por: Xu, Lu, et al.
Publicado: (2019)

Sclerosing Stromal Tumor of the Ovary: MR-Pathologic Correlation in Three Cases
por: Kim, Jin Young, et al.
Publicado: (2003)

Basic Pancreatic Lesions: Radiologic-pathologic Correlation
por: Bian, Yun, et al.
Publicado: (2022)

Is remnant pancreatic cancer after pancreatic resection more frequent in early‐stage pancreatic cancer than in advanced‐stage cancer?
por: Miyasaka, Yoshihiro, et al.
Publicado: (2020)

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
por: Wang, Zhe-Ying, et al.
Publicado: (2019)

Data of ‘Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage’
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Diagnostic Accuracy of CT for Evaluating Circumferential Resection Margin Status in Resectable or Borderline Resectable Pancreatic Head Cancer: A Prospective Study Using Axially Sliced Surgical Pathologic Correlation
por: Park, Ji Hoon, et al.
Publicado: (2022)

High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Song, Yang, et al.
Publicado: (2020)

FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer
por: Davidson, Catherine, et al.
Publicado: (2022)

Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma
por: Dal Molin, Marco, et al.
Publicado: (2016)

The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2023)

Value of Pretreatment (18)F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy
por: Barnes, Chad A., et al.
Publicado: (2020)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors
por: Jutric, Zeljka, et al.
Publicado: (2015)

Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer
por: Choi, Young Hoon, et al.
Publicado: (2022)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
por: Veenstra, V. L., et al.
Publicado: (2018)

Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation
por: Koch, M.R., et al.
Publicado: (2013)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2009)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2010)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival
por: Fagman, Johan Bourghardt, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_shhhj01dn4pf9jo0shcacp82ot